A new publication in Nature Communications describes the development and mechanism of action of new allosteric inhibitors that show promise for further development into a selective but efficacious therapeutic.
Robert Vince, PhD, director of the Center for Drug Design at the University of Minnesota, has been selected as the 2022 Lawrence C. and Delores M. Weaver Medal recipient.
The Department of Medicinal Chemistry held our 2nd Annual DEI Potluck at Como Park in St. Paul over Memorial Day weekend.
Dr. Courtney Aldrich and Dr. Elizabeth Ambrose were both elected to serve a three-year term on the faculty senate.
The Department of Medicinal Chemistry's STEAM Team attended a science-focused poster session hosted by Thomas Edison High School as part of a continued outreach program that focuses on student mentoring in the sciences.
Over the past decades we have learned that cancer is a very complex disease. There are many forms of cancer arising from organ specific malignancies that can further metastasize to other organs. Tumors themselves are now recognized to not just be one type of cell but a community of many different types of cells, including many types of tumor cells. Key among these cells are what are being called cancer stem cell like cells or CSCs.